Signal Export licences and tariff relief converted into revenue and price concessions

Summary

Two chipmakers agreed to hand the Treasury between fifteen and twenty-five per cent of their China semiconductor revenue, and a pharmaceutical firm accepted lower drug prices, sales through a federal portal and US manufacturing investment in return for tariff relief.